Certolizumab pegol treatment for leg ulcers due to rheumatoid vasculitis.

Meling, Maureen Tania; Minagawa, Akane; Miyake, Tomomi; Ashida, Atsuko; Okuyama, Ryuhei

Meling, Maureen Tania; Minagawa, Akane; Miyake, Tomomi; Ashida, Atsuko; Okuyama, Ryuhei.

Afiliación

Meling MT; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.
Minagawa A; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.
Miyake T; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.
Ashida A; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.
Okuyama R; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.

JAAD Case Rep ; 18: 12-14, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34786446

Palabras clave

CZP, certolizumab pegol; MTX, methotrexate; PSL, prednisolone; RA, rheumatoid arthritis; RV, rheumatoid vasculitis; TNF-α inhibitor; TNF-α, tumor necrosis factor-alfa; autoimmune disease; biological therapy; certolizumab pegol; leg ulcer; rheumatoid arthritis; rheumatoid vasculitis; skin ulcer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google